Seasonal Influenza (Flu)
- 2012-2013 Flu Season
- 2011-2012 Flu Season
- Influenza - Flu Basics
- Key Facts About Seasonal Flu
- Influenza Viruses
- Symptoms & Severity
- How Flu Spreads
- Flu Season
- Past Flu Seasons
- Questions & Answers
- Seasonal Influenza (Flu): Q&A
- Vaccine Selection for the 2010–2011 Influenza Season
- Influenza (Flu) Research
- Reconstruction of the 1918 Influenza Pandemic Virus
- Seasonal Influenza: Q&A
- Seasonal Influenza-Associated Hospitalizations in the United States
- Misconceptions about Seasonal Influenza and Influenza Vaccines
- Other Respiratory Viruses
- Cold Versus Flu
- Seasonal Flu & Staph Infection
- Prevention - Flu Vaccine
- Take 3 Actions To Fight The Flu
- Key Facts About Seasonal Flu Vaccine
- Vaccine Safety
- 2011-2012 Vaccine Safety Q&A
- Vaccine Safety Monitoring Systems Q&A
- Approved Influenza Vaccines
- Who Should Get Vaccinated Against Influenza
- Intradermal Influenza (Flu) Vaccination
- Fluzone High-Dose Seasonal Influenza Vaccine
- Children, the Flu, and the Flu Vaccine
- Caregivers of Children Less Than 6 Months Old
- Seasonal Flu Vaccine Safety and Pregnant Women
- Q&A on Febrile Seizures
- Good Health Habits
- Questions & Answers
- National Influenza Vaccination Week (NIVW)
- Treatment - Antiviral Drugs
- Specific Groups
- Health Professionals
- ACIP Recommendations
- 2011-12 Vaccination Recommendations
- Summary of Influenza Vaccination Recommendations
- Introduction and Biology of Influenza
- Options for Controlling Influenza
- Influenza Vaccine Composition
- Major Differences Between TIV and LAIV
- Recommendations for Using TIV and LAIV During the Influenza Season
- Dosage, Administration, and Storage
- Persons for Whom Annual Vaccination is Recommended
- Persons Who Should Not Be Vaccinated
- Vaccination of Specific Populations
- Shedding, Transmission, and Stability of LAIV Viruses
- Influenza Vaccines and Use of Influenza Antiviral Medications
- Concurrent Administration of Influenza Vaccine With Other Vaccines
- Adverse Events After Receipt of TIV
- Adverse Events After Receipt of LAIV
- Timing of Vaccination
- Vaccine Supply Considerations
- Evaluating Vaccine Studies
- Vaccination
- Vaccine Supply Update
- Influenza Vaccination: A Summary for Clinicians
- Seasonal Influenza Vaccine Safety: A Summary for Clinicians
- Selecting the Viruses in the Influenza (Flu) Vaccine
- Large-Scale Influenza Vaccination Clinic Planning
- Flu Vaccine Effectiveness
- Reallocating Influenza Vaccine
- Vaccination Information for Health Care Workers
- FluVaxView Influenza Vaccination Coverage
- Summary Flu Vaccination Trends (2007-08 through 2010-11)
- 2011-12 Flu Season, National Immunization Survey and National Flu Survey, March 2012
- 2011-12 Flu Season, National Flu Survey, November 2011
- 2011-12 Flu Season, Health Care Personnel (Internet Panel Survey)
- 2011-12 Flu Season, Pregnant Women (Internet Panel Survey)
- 2010–11 Final State-Level Flu Vaccination Estimates
- 2010–11 Flu Season, Interactive Map (Report I)
- 2010–11 Flu Season, Comparison Table (Report II)
- 2009–10 Flu Season, Final State-Level Seasonal and H1N1 Flu Vaccination Estimates
- 2009–10 Flu Season, Interactive Map (Report I)
- 2009–10 Flu Season, Comparison Table (Report II)
- 2009-10 Flu Season, Influenza Vaccination Among Women with a Recent Live Birth (PRAMS)
- 2008–09 Flu Season, Flu Vaccination Estimates, Children Aged 6–23 Months
- Antiviral Drugs
- Influenza Antiviral Medications: Summary for Clinicians
- Antiviral Agents for Influenza
- Antiviral Drug Resistance Among Influenza Viruses
- Use of Antivirals
- Dosage
- Adverse Events
- Drug Interactions
- Emergency Use Authorization
- Specific Populations
- Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications
- Additional Links and Resources
- References
- Infection Control
- Prevention Strategies for Seasonal Influenza in Healthcare Settings
- Interim Guidance for Influenza Outbreak Management in Long-Term Care Facilities
- Control of Influenza Outbreaks in Institutions
- Settings Where High-Risk Persons & Their Contacts May Be Targeted For Vaccination
- Prevention & Control of Influenza in the Peri- and Postpartum Settings
- Interim Guidance for the Use of Masks to Control Influenza Transmission
- Respiratory Hygiene/Cough Etiquette
- Clinical Description & Lab Diagnosis
- Influenza Symptoms and the Role of Laboratory Diagnostics
- Rapid Diagnostic Testing: Information for Health Care Professionals
- Rapid Diagnostic Testing: Information for Clinical Laboratory Directors
- Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests
- Guidance for Clinicians on the Use of RT-PCR and Other Molecular Assays for Diagnosis of Influenza Virus Infection
- Clinical Signs and Symptoms of Influenza
- International Influenza
- Training
- References & Resources
- Communications to Health Care Providers
- ACIP Recommendations
- Information For Partners
- Flu Activity & Surveillance
- Situation Update: Summary of Weekly FluView
- Overview of Influenza Surveillance in the United States
- Current United States Flu Activity Map
- Weekly U.S. Influenza Surveillance Report
- Past Weekly Surveillance Reports
- United States Surveillance Data: 1997-1998 through 2005-2006 Seasons
- Estimating Seasonal Influenza-Associated Deaths in the United States
- Staph Infections
- Avian Flu
- Swine Flu
- Influenza A (H3N2) Variant Virus Outbreaks
- Situation Summary
- Past Updates
- Case Count
- H3N2v and You
- Prevention
- Treatment
- Health Care Providers
- Prevention Strategies for Seasonal and Influenza A(H3N2)v in Health Care Settings
- Interim Information for Clinicians about Human Infections with H3N2v Virus
- Interim Guidance for Enhanced Influenza Surveillance: Additional Specimen Collection for Detection of Influenza A (H3N2) Variant Virus Infections
- Interim Guidance on Specimen Collection, Processing, and Testing for Patients with Suspect Influenza A(H3N2)v Virus Infection
- Interim Guidance on Case Definitions to be Used For Investigations of Influenza A(H3N2)v Virus Cases
- Guidance for Public Health
- Other Guidance Documents
- News & Highlights
- Materials & Resources
- Specific Audiences
- National Influenza Vaccination Week (NIVW)
- Vaccination Pledge
- What's New & Updated!
- Free Resources
- Other Flu Web Sites
Share
Compartir
- Add this to...
- Añadir en...
- Favorites
- Delicious
- Digg
- Google Bookmarks
Seasonal Influenza Vaccine & Total Doses Distributed
- This table reflects the cumulative weekly total number of seasonal influenza vaccine doses distributed in the US as reported to CDC by influenza vaccine manufacturers and selected distributors. This includes doses produced by all US-licensed manufacturers distributed in public and private sectors.
September 13, 2012 12:00 PM ET
Table of 2012-13 Seasonal Influenza Vaccine—Total Doses Distributed
Week | Total Doses Distributed |
---|---|
09/07/12 | ≈ 72.6 million doses |
≈ = approximate |
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - cdcinfo@cdc.gov